Rapid tests for COVID-19 emerged from major investment by the United Kingdom's controversial Moonshot program, a £100 billion program to systematically assess, develop and implement new technologies for COVID-19 testing.[4] Rapid tests initially sat within this systematic evaluation pipeline alongside many other putative COVID-19 testing technologies like Lamp, Lampore, point of care PCR, mass spectrometry and sample pooling. However, as evaluations continued, rapid tests emerged as the most successful form of COVID-19 testing within this program to complement existing PCR testing.